SELEGILINE HYDROCHLORIDE 5 mg/1
SELEGILINE HYDROCHLORIDE · CAPSULE · Apotex Corp.
Selegiline hydrochloride is a prescription medication used to treat Parkinson's disease, often taken alongside levodopa therapy to help manage symptoms. It works by blocking the breakdown of dopamine in the brain, helping to preserve the effects of other Parkinson's medications.
Key Facts
- Brand Name
- SELEGILINE HYDROCHLORIDE
- Generic Name
- SELEGILINE HYDROCHLORIDE
- NDC Code (Product)
60505-0055- Manufacturer
- Apotex Corp.
- Strength
- 5 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA075321
- Marketing Start
- 07/15/1997
Recall History
No Recall HistoryFrequently Asked Questions
What is SELEGILINE HYDROCHLORIDE used for?
Selegiline hydrochloride is a prescription medication used to treat Parkinson's disease, often taken alongside levodopa therapy to help manage symptoms. It works by blocking the breakdown of dopamine in the brain, helping to preserve the effects of other Parkinson's medications.
Is SELEGILINE HYDROCHLORIDE a controlled substance?
SELEGILINE HYDROCHLORIDE is not classified as a controlled substance by the DEA.
What is the generic name for SELEGILINE HYDROCHLORIDE?
The generic name for SELEGILINE HYDROCHLORIDE is SELEGILINE HYDROCHLORIDE. There are 11 other brand versions of SELEGILINE HYDROCHLORIDE.
What is the NDC code for SELEGILINE HYDROCHLORIDE 5 mg/1?
The NDC (National Drug Code) for SELEGILINE HYDROCHLORIDE 5 mg/1 is 60505-0055, listed by Apotex Corp..
Other Selegiline Brands
See all →- Selegiline Hydrochloride5 mg/150090-2918
- Selegiline Hydrochloride5 mg/171335-2673
- Selegiline Hydrochloride5 mg/160505-3438
- Selegiline Hydrochloride5 mg/171205-888
- Selegiline Hydrochloride5 mg/116571-659
- ZELAPAR1.25 mg/10187-0453
- Selegiline Hydrochloride5 mg/162135-694
- Selegiline Hydrochloride5 mg/160429-176
- Selegiline Hydrochloride5 mg/171335-2676
- Selegiline Hydrochloride5 mg/170954-504
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)